Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapyM. Marty, V. Stahalova, Antonio Llombart‐Cussac et al.|Annals of Oncology|2006Cited by 197